Heist, Germany

York Hartleben


Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • 2081 Heist, DE (1979)
  • Heist, DE (1978 - 1982)

Company Filing History:


Years Active: 1978-1982

Loading Chart...
4 patents (USPTO):Explore Patents

Title: York Hartleben: Innovator in Pharmaceutical Chemistry

Introduction

York Hartleben is a notable inventor based in Heist, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds for medical applications, particularly in treating infections and neurological conditions.

Latest Patents

Hartleben's latest patents include the development of tertiary imidazolyl alcohols, which are aimed at treating generalized and local infections caused by fungi or yeasts. The invention involves administering these compounds in suitable pharmaceutical preparations to mammals suffering from such diseases. Another significant patent is for 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one, which addresses somnipathy, tension conditions, and epilepsy in humans through the use of specific oxazolidin-2-one derivatives.

Career Highlights

Throughout his career, Hartleben has worked with prominent companies such as Nordmark-Werke GmbH and BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Some of Hartleben's notable coworkers include Klaus Gutsche and Friedrich-Gero Kollensperger. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

York Hartleben's innovative work in pharmaceutical chemistry has led to the development of important medical compounds. His contributions continue to impact the treatment of various health conditions, showcasing the significance of his inventions in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…